Point of care testing is one of the fastest-growing segments within the U.S. in vitro diagnostics industry. Rather than sending a patient sample to a central laboratory and waiting hours for results, ...Read More
The leading in vitro diagnostics market companies are competing in a U.S. market valued at $23.9 billion in 2025, and projected to reach $31.8 billion at a 4.2% CAGR through the forecast period. This ...Read More
Top 5 Market Trends in In vitro Diagnostics The U.S. in vitro diagnostics (IVD) market continues to play a central role in modern healthcare. These tests, performed on blood, urine, and other samples,...Read More